1 xiety, appetite loss, physical symptoms, and restlessness.

2 fferential diagnosis of genital symptoms and restlessness, along with nonmotor wearing off and akathi

3 ed temporary behavioural changes as shown by restlessness and abdominal stretchings but did not resul

4 al and death-related thoughts, hopelessness, restlessness and agitation, insomnia and impulsiveness a

5 netic involuntary movements, including motor restlessness and chorea, slowing of voluntary movements

6             Aggression, anger, irritability, restlessness, and strange dreams increased significantly

7 re was less insomnia, fatigue, sedation, and restlessness associated with cognitive behavioral therap

8 eports" for high, drug effects, anxiety, and restlessness), cardiovascular (pulse rate and diastolic

9 f age) with assessment of insomnia symptoms (restlessness, difficulty falling asleep, waking at night

10 /-4, P < or = 0.02; E2: +4+/-4, P = 0.1) and restlessness (E1: +4+/-4, P < or = 0.04; E2: +4+/-5, P =

11 rder is characterised by feelings of threat, restlessness, irritability, sleep disturbance, and tensi

12 remors (two episodes), apnea (two episodes), restlessness (one episode).

13  commonly retro-orbital, pain accompanied by restlessness or agitation, and cranial (parasympathetic)

14 bserved that the Btbd9 mutant mice had motor restlessness, sensory alterations likely limited to the

15 and less irritability, anxiety, craving, and restlessness than placebo.